AI visibility score
4.2/ 10Fair

#46,659 of 924,420 in Healthcare

As of 2026-08-08 · Engagemii indexCheck another site →The index →

AI Visibility Scorecard

Hereditary Leiomyomatosis and Renal Cell Cancer

Hereditary Leiomyomatosis and Renal Cell Cancer

Unclaimed

hlrcc.org · Healthcare

Borderline visible. AI bots can crawl Hereditary Leiomyomatosis and Renal Cell Cancer, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.

AI engines read this profile 6 times

Meta AI · Claude · ShapBot

#46,659 of 924,420 in Healthcare for AI visibility

<1

AI Naming Predictability

i

Rarely named · <1/100

Top 19% of Healthcare

4

AEO Visibility

i

Borderline · 4.2/10

5

Muse Index Score

i

AI agent readiness

Basic · 5/100

0

AI Adoption

i

None detected · 0/100

Share

About Hereditary Leiomyomatosis and Renal Cell Cancer

from our crawl and measurement

Hereditary Leiomyomatosis and Renal Cell Cancer is a business whose own site puts it this way: "Hereditary Leiomyomatosis and Renal Cell Cancer [email protected] +1 617-277-5667 ext." When AI engines look at it, they find little to work with. It scores 4.2 out of 10.

Our crawl found a sitemap and a readable heading structure. It is missing structured data describing the business and an llms.txt file.

AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).

Industry · Healthcare
Last scored · Aug 8, 2026

The 6 signals AI reads

Strong · Good · Fair · Weak

Structured Data

Weak

Organization / LocalBusiness JSON-LD that AI can read.

Content Structure

Strong

Clear headings and answer-style content.

Entity Clarity

Good

How clearly your brand identity reads to AI.

E-E-A-T Signals

Experience, Expertise, Authority, Trust

Good

Experience, Expertise, Authority, Trust markers.

Technical AEO

Good

robots.txt, llms.txt, and AI-bot crawl access.

AI Discoverability

Strong

Sitemaps and entity links AI can follow.

Off-page authority

How the web signals your brand to AI

Backlinks

Strong

Inbound links from other sites.

Domain Authority

Weak

Little domain authority yet.

Reference Presence

Weak

Not in AI knowledge graphs yet.

News & Press

Weak

No press coverage found yet.

Community

Weak

No community discussion yet.

Social Mentions

Weak

No social discussion found yet.

What this score means

Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.2/10, Hereditary Leiomyomatosis and Renal Cell Cancer is crawlable but under-signaled - fixable, and the signals above are where to start.

Frequently Asked Questions

How do I test for HLRCC?

HLRCC (Hereditary Leiomyomatosis and Renal Cell Cancer) genetic testing typically involves a blood or saliva sample, which is sent to a laboratory for analysis. Learn how to order an in home genetic test to see if you have HLRCC here.

How do I find a Clinical Care Center (CCC)?

To find a VHL and HLRCC dedicated Clinical Cancer Center (CCC) with a multidisciplinary team experienced in HLRCC, please click here. A list of CCCs are maintained by our partner, the VHL Alliance, and are dedicated to providing specialized care and support to individuals with HLRCC and other related conditions.

How do I enroll in the HLRCC Natural History Study or Seek Expert Guidance at the NIH?

To find out how to reach out to the NIH for expert opinion or to find an expert in HLRCC near you, please click here. The NIH offers a range of resources for individuals and healthcare providers managing HLRCC, including clinical trials and research initiatives aimed at improving outcomes for those affected by the condition.

How do I find a clinical trial?

Clinical trials are critical for advancing the treatment and management of HLRCC. By participating in clinical trials, individuals with HLRCC and variant histology renal cell cancer can potentially access new and innovative treatments.

I am a physician, where can I find more information?

For physicians and healthcare providers seeking more information about HLRCC, please click here. We provide a range of resources, including clinical guidelines, expert recommendations, and updates on ongoing research and clinical trials. We are dedicated to supporting healthcare providers in the diagnosis, management, and treatment of HLRCC.

Is this your brand?

✓

The exact fixes for Hereditary Leiomyomatosis and Renal Cell Cancer

✓

Which AI engines already crawl you

✓

Free AI bot monitoring: see every AI crawler that visits you

Claim your page free

Already have an account? Sign in

Picked for Hereditary Leiomyomatosis and Renal Cell Cancer: How-To

How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide

The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for Hereditary Leiomyomatosis and Renal Cell Cancer.

Source & Attribution

Scored by Engagemii on August 8, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/hlrcc-org

Cite this score: Engagemii (2026). "AEO Score for Hereditary Leiomyomatosis and Renal Cell Cancer." Retrieved from https://engagemii.com/aeo/brands/hlrcc-org

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - The Answer Engine Optimization (AEO) Platform